| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.805 | 6.481 | 6.159 | 9.680 | 9.675 | 10.686 | 32.946 | 13.908 | 4.843 | 11.151 |
| Total Income - EUR | 5.805 | 6.483 | 6.218 | 10.305 | 9.728 | 12.693 | 33.079 | 14.215 | 4.919 | 12.513 |
| Total Expenses - EUR | 4.164 | 5.987 | 5.693 | 9.086 | 8.647 | 9.542 | 8.429 | 11.992 | 5.545 | 9.048 |
| Gross Profit/Loss - EUR | 1.641 | 497 | 526 | 1.219 | 1.081 | 3.151 | 24.650 | 2.222 | -626 | 3.465 |
| Net Profit/Loss - EUR | 1.356 | 417 | 340 | 914 | 789 | 2.831 | 23.661 | 1.860 | -626 | 2.910 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Aslon Bioex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 148 | 583 | 0 | 1.554 | 1.109 | 1.721 | 822 |
| Current Assets | 3.680 | 6.059 | 9.727 | 13.621 | 19.174 | 19.072 | 40.376 | 38.645 | 35.126 | 29.214 |
| Inventories | 2.694 | 4.720 | 8.510 | 9.341 | 12.451 | 12.935 | 16.182 | 31.217 | 29.358 | 26.526 |
| Receivables | 9 | 0 | 92 | 3.359 | 6.048 | 4.284 | 15.512 | 2.172 | 1.640 | 796 |
| Cash | 0 | 1.339 | 1.125 | 922 | 675 | 1.853 | 8.681 | 5.256 | 4.129 | 1.892 |
| Shareholders Funds | 1.137 | 1.542 | 1.856 | 2.736 | 3.472 | 6.237 | 29.628 | 31.580 | 30.858 | 29.444 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.543 | 4.517 | 7.871 | 11.142 | 16.284 | 12.835 | 12.302 | 8.174 | 5.989 | 593 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Aslon Bioex Srl